Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 02, 2022

Ipsen Biopharm Ltd v. Galderma Laboratories LP et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 08, 2023

    Judge Says Ipsen IP Row Belongs In Belgium

    A Texas federal judge on Wednesday threw out Ipsen Biopharm's trade secrets suit against Galderma Laboratories over an application seeking federal approval of a Botox-like treatment, pointing out the companies' "erratic posturing" before leaving the dispute up to a Belgian arbitration tribunal.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login